Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

27.79 -0.57 (-2.01%)
Streaming Delayed Price Updated: 12:19 PM EST, Jan 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Fulgent Genetics Reports Second Quarter 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Announces Launch of PCR Based Test to Detect Monkeypox
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics to Announce Second Quarter 2022 Financial Results on Thursday, August 4, 2022
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Reports First Quarter 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Announces Promotions and Leadership Updates
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Announces Opening of New State-of-the-Art Oncology Laboratory in El Monte, California
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Agrees to Acquire Inform Diagnostics and Provides Preliminary First Quarter Revenue Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics to Announce First Quarter 2022 Financial Results on Tuesday, May 3, 2022
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Announces Strategic Investment in Spatial Genomics
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Reports Fourth Quarter and Full Year 2021 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics to Announce Fourth Quarter and Full Year 2021 Financial Results on Wednesday February 23, 2022
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
HelioLiver™, an Innovative Liquid Biopsy Test for the Early Detection of Liver Cancer, is Now Commercially Available
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Confirms Ability to Detect Omicron Variant with RT-PCR Tests for COVID-19
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Reports Third Quarter Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Representatives of Fulgent Genetics to Participate in Upcoming Virtual Conferences
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Launches At-Home Neutralizing Antibody Test for COVID-19
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics to Announce Third Quarter 2021 Financial Results on Tuesday November 9, 2021
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics to Partner with Houston Health Department and Houston-Area Public Schools on Back-to-School COVID-19 Testing Program
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Reports Second Quarter Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Announces Acquisition of CSI Laboratories
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
CORRECTING and REPLACING Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
From Fulgent Genetics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.